Aurora Cannabis Appoints New Executive to Lead Global Expansion

Aurora Cannabis Inc., a prominent Canadian company in the global medical cannabis market, has announced the appointment of Faris El Refaie as the new executive responsible for driving the commercial acceleration of its business. El Refaie brings extensive experience in the biopharmaceutical industry, which the company believes will facilitate its strategic growth objectives. The move is seen as a critical step in Aurora's efforts to solidify its presence in the international medicinal cannabis arena and enhance its operational capabilities. Aurora continues to focus on leveraging its expertise and resources to develop innovative cannabis products and expand its market reach. As the medical cannabis industry evolves, Aurora aims to position itself as a leader in providing high-quality cannabis-based therapies.